p38 MAP kinase activation mediates γ-globin gene induction in erythroid progenitors

Experimental Hematology

Volumn 31, Issue 11, 2003, Pages 1089-1096

  Pace, Betty S ^a   Qian, Xin Hua ^b   Sangerman, Jose ^a   Ofori Acquah, Solomon F ^b   Baliga, B Surendra ^c   Han, Jiahuai ^d   Critz, Stuart D ^b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

^c UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANISOMYCIN; BUTYRIC ACID; GAMMA GLOBIN; HEMIN; HEMOGLOBIN F; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 6; RNA; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ARTICLE; CELL ASSAY; CELL CULTURE; CELL STRAIN K 562; CONTROLLED STUDY; DENATURATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ERYTHROID PRECURSOR CELL; ERYTHROLEUKEMIA CELL; GENE ACTIVITY; GENE FUNCTION; GENE INDUCTION; HUMAN; HUMAN CELL; MESSENGER RNA SYNTHESIS; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RIBONUCLEASE PROTECTION ASSAY; WESTERN BLOTTING;

EID: 0142165059     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(03)00235-2     Document Type: Article

References (42)

1. Nakajima H., Kim Y.B., Terano H., Yoshida M., Horinouchi S. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor. Exp Cell Res. 241:1998;126-133.
2. Yamashita T., Wakao H., Miyajuma A., Asano S. Differentiation inducers modulate cytokine signaling pathways in a murine erythroleukemia cell line. Cancer Res. 58:1998;556-561.
3. Robinson M.J., Cobb M.H. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol. 9:1997;180-186.
4. Ip Y.T., Davis R.J. Signal transduction by the c-jun N-terminal kinase (JNK) - from inflammation to development. Curr Opin Cell Biol. 10:1998;205-219.
5. Kyriakis J.M., Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev. 81:2001;807-869.
6. Witt O., Sand K., Pekrun A. Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways. Blood. 95:2000;2391-2396.
7. Conrad P.W., Rust R.T., Han J., Milhorn D.E., Beitner-Johnson D. Selective activation of p38α and p38γ by hypoxia. J Biol Chem. 274:1999;23570-23576.
8. Jacobs-Helber S.M., Ryan J.J., Sawyer S.T. JNK and p38 are activated by erythropoietin (EPO) but are not induced in apoptosis following EPO withdrawal in EPO-dependent HCD57 cells. Blood. 96:2000;933-940.
9. Kouzarides T. Histone acetylases and deacetylases in cell proliferation. Curr Opin Genet Dev. 9:1999;40-48.
10. Norton V.G., Imai B.S., Yau P., Bradburg E.M. Histone acetylation reduces nucleosome core particle linking number change. Cell. 57:1989;449-457.
11. Dobson M.E., Ingram V.M. In vitro transcription of chromatin containing histones hyperacetylated in vivo. Nucleic Acids Res. 8:1980;4201-4219.
12. Riggs M.G., Whittaker R.G., Neuman R.G., Ingram V.M. N-butyrate causes histone modification in HeLa and Friend erythroleukemia cells. Nature. 268:1977;462-464.
13. McCaffrey P.G., Newsome D.A., Fibach E., Yoshida M., Su M.S. Induction of γ-globin by histone deacetylase inhibitors. Blood. 90:1997;2075-2083.
14. Yoshida M., Kijima M., Akita M., Beppu T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem. 265:1990;17174-17179.
15. Curenda A., Rouse J., Doza Y.N., et al. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stress and interleukin-1. FEBS Lett. 64:1995;229-233.
16. Cano E., Doza Y.N., Ben-Levy R., Cohen P., Mahadevan L. Identification of anisomycin-activated kinases p45 and p55 in murine cells as MAPKAP kinase-2. Oncogene. 2:1996;805-812.
17. Raingeaud J., Whitmarsh A.J., Barrett T., Derijard B., Davis R.J. MKK3- and MKK6-regulated gene expression is mediated by p38 mitogen-activated protein kinase signal transduction pathway. Mol Cell Biol. 6:1996;1247-1255.
18. Jiang Y., Chen C., Li Z., et al. Characterization of the structure and function of a new mitogen-activated protein kinase (p38β). J Biol Chem. 271:1996;17920-17926.
19. Yang Y., Pace B.S., Kitchens D., Ballas S.K., Shah A., Baliga B.S. Characterization of in vitro BFU-E colony growth and fetal hemoglobin production in response to hydroxyurea: an analysis of the relationship to in vivo fetal hemoglobin induction. Am J Hematol. 56:1997;252-258.
20. Baliga B.S., Pace B.S., Chen H., Shah A.K., Yang Y. Mechanism for induction of fetal hemoglobin synthesis by hydroxyurea in sickle cell erythroid progenitors. Am J Hematol. 65:2000;227-233.
21. Wang Y., Huang S., Sah V.P., et al. Cardiac muscle hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem. 273:1998;2161-2168.
22. Reuter C.W.M., Morgan M.A., Bergmann L. Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies? Blood. 96:2000;1655-1669.
23. Levitzki A. Tyrphostins - potential antiproliferative agents and novel molecular tools. Biochem Pharmacol. 40:1990;913-918.
24. Enslen H., Raingeaud J., Davis R.J. Selective activation of p38 mitogen-acitvated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J Biol Chem. 273:1998;1741-1748.
25. Boosalis M.S., Bandyopadhyay R., Bresnick E.H., et al. Short-chain fatty acid derivatives stimulate cell proliferation and induce STAT-5 activation. Blood. 97:2001;3259-3267.
26. Pace B.S., White G.I., Dover G.J., Boosalis M.S., Thies A., Perrine S.P. Short chain fatty acid derivatives induce fetal globin expression and erythropoiesis in vivo. Blood. 100:2002;4640-4648.
27. Caldenhoven E., van Dijk T.B., Solari R., et al. STAT3β, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription. J Biol Chem. 271:1996;13221-13227.
28. Foley H., Ofori-Acquah S., Yoshimura A., Critz S., Baliga B.S., Pace B.S. Stat3β inhibits γ-globin gene expression in erythroid cells. J Biol Chem. 277:2002;16211-16219.
29. Ikuta T., Ausenda S., Cappellini M.D. Mechanism for fetal globin gene expression: role of the soluble guanylate cyclase-cGMP-dependent protein kinase pathway. Proc Natl Acad Sci U S A. 98:2001;1847-1852.
30. Zechner D., Craig R., Hanford D.S., McDonough P.M., Sabbadini R.A., Glembotski C.C. MKK6 activates myocardial cell NF-κB and inhibits apoptosis in a p38 mitogen-activated protein kinase-dependent manner. J Biol Chem. 273:1998;8232-8239.
31. Perrine S.P., Ginder G.D., Faller D.V., et al. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the β-globin disorders. N Engl J Med. 328:1993;81-86.
32. Atweh G.F., Sutton M., Nassif I., et al. Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease. Blood. 93:1999;1790-1797.
33. Glauber J.G., Wandersee N.J., Little J.A., Ginder G. 5′ flanking sequences mediate butyrate stimulation of embryonic globin gene expression in adult erythroid cells. Mol Cell Biol. 11:1991;4690-4697.
34. Bohan C., Robinson R.A., Luciw P.A. Mutational analysis of sodium butyrate inducible elements in the human immunodeficiency virus type I long terminal repeat. Virology. 172:1989;573-583.
35. Ikuta T., Kan Y.W., Swerdlow P.S., Faller D.V., Perrine S.P. Alterations in protein-DNA interactions in the γ globin gene promoter in response to butyrate therapy. Blood. 92:1998;2924-2933.
36. Pace B.S., Chen Y.R., Thompson A., Goodman S.R. Butyrate inducible elements in the human Aγ globin gene promoter. Exp Hematol. 28:2000;283-293.
37. Nagata Y., Todokoro K. Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis. Blood. 94:1999;853-863.
38. Witt O., Monkemeyer S., Ronndahl G., et al. Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin. Blood. 101:2003;2001-2007.
39. Wang G.L., Jiang B.H., Rue E.A., Semenza G.L. Hypoxia-inducible factor 1 is a basic-helix-helix-PAS heterodimer regulated by cellular oxygen tension. Proc Natl Acad Sci U S A. 92:1995;5510-5514.
40. Nakajima H., Kim Y.B., Terano H., Yoshida M., Horinouchi S. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor. Exp Cell Res. 241:1998;126-133.
41. Raingeaud J., Rogers J.S., Dickens M., Han J., Ulevitch R.J., Davis R.J. Pro-inflammatory cytokines and environmental stress cause p38 mitogenactivated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem. 270:1995;7420-7426.
42. Ziff E.B. Transcription factors: a new family gathers at the camp response site. Trends Genet. 6:1990;69-72.